Dow Jones VentureSource revealed its Q3 2011 venture capital report this morning, and we wanted to congratulate them on confirming what CB Insights had revealed in our Q3 Venture Capital Activity Report issued more than a week ago.
Specifically, they did do a nice job restating our earlier findings including:
- Early stage activity is up (more details on that here)
- NY overtook Massachusetts on both VC deals & dollars
- VC levels are back to pre-recession levels
- Medical device companies were a hot area in healthcare
Year-to-date in 2011, we’ve tracked $23 billion of financing compared to VentureSource at $22.8 billion. We’ve tracked 2,296 VC deals and VentureSource has 2,202 deals.
Below is the CB Insights vs. VentureSource data for each of the first three quarters of 2011 by quarter. For a prior comparison of CB Insights VC data vs. VentureSource, you can also check out this venture capital database comparison.